Masimo announces FDA clearance for Masimo RD sensors
Masimo announced that RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry have received FDA clearance with improved SpO2 accuracy specifications for all patients greater than 3 kg. RD SET single-patient-use sensors with the improved accuracy specifications are now available. The new RD SET sensors' SpO2 accuracy specifications during patient motion have improved for adult, pediatric, and infant patients to 1.5%, compared to previous accuracy specifications of 3%. In addition to offering improved accuracy, RD SET sensors are designed to enhance patient comfort, optimize clinician workflows, and help hospitals meet green initiatives. The sensors are lightweight and have a flat, soft cable with smooth edges, so that they lie comfortably on a patient's hand or foot. The sensors feature an intuitive sensor-to-cable connection. Their lightweight design results in up to 84% less waste, and their sleek, recyclable packaging reduces storage and shipping space.